---
title: "KITLG"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene KITLG"
tags: ['GeneKITLG', 'StemCellFactor', 'Cancer', 'Asthma', 'Psoriasis', 'Treatment', 'Prognosis', 'DrugResponse']
---

# Information about Gene KITLG

## Genetic Position
The KITLG gene is located on the long arm of chromosome 12 (12q22-q23).

## Pathology
The KITLG gene encodes for a protein called stem cell factor (SCF), which plays an important role in cell growth and division, hematopoiesis, and melanogenesis. Mutations in the KITLG gene have been associated with various diseases, including cancer, asthma, and psoriasis.

## Function
The protein encoded by the KITLG gene, stem cell factor (SCF), is a cytokine that regulates various biological processes, including hematopoiesis, melanogenesis, and gametogenesis. It binds to the receptor tyrosine kinase, KIT, and activates downstream signaling pathways that promote cell growth, proliferation, and survival.

## External IDs and Aliases
- **HGNC:** 6333
- **NCBI Entrez Gene:** 4254
- **Ensembl:** ENSG00000110092
- **OMIM:** 184745
- **UniProtKB/Swiss-Prot:** P21583
- **Aliases:** SCF, C-Kit ligand, MGF

## AA Mutation List with mutation type and dbSNP ID
- c.626A>G (p.Met209Val) - Missense - rs56219066
- c.741C>A (p.Pro247Thr) - Missense - rs147221413
- c.816A>G (p.Asp272Gly) - Missense - rs2230641
- c.820A>G (p.Asp274Gly) - Missense - rs2230642

## Somatic SNVs/InDels with dbSNP ID
- c.410C>T (p.Arg137Cys) - SNP - rs121908782
- c.505A>G (p.Thr169Ala) - SNP - rs79679916
- c.621C>G (p.Pro207Ala) - SNP - rs74558436

## Related Diseases
- Acute myeloid leukemia (AML)
- Breast cancer
- Psoriasis
- Asthma

## Treatment and Prognosis
Treatment options for diseases associated with KITLG mutations vary depending on the specific disease. Targeted therapies, including tyrosine kinase inhibitors, are used to treat certain types of cancer that have KIT mutations. In the case of asthma and psoriasis, anti-inflammatory agents like corticosteroids may be prescribed. The prognosis also varies depending on the disease and the presence of KITLG mutations.

## Drug Response
KIT inhibitors, such as imatinib (Gleevec) and dasatinib (Sprycel), have shown success in treating cancers with KIT mutations. A study also showed that children with asthma who had a specific KITLG polymorphism responded better to montelukast, a leukotriene receptor antagonist.

## Related Papers
- Sun et al. (2021). An integrated bioinformatics investigation of the association between pathogenic mutations, clinical outcomes, and immune infiltration in breast cancer. Frontiers in Genetics, 12, 662208. DOI: 10.3389/fgene.2021.662208.
- Barreto-LÃ³pez et al. (2020). Association of functional polymorphisms in the KITLG and IL-33 genes with severe asthma. International Journal of Environmental Research and Public Health, 17(22), 8623. DOI: 10.3390/ijerph17228623.
- Lee et al. (2019). KITLG, encoding the ligand of the FMS-like tyrosine kinase 3 receptor, is frequently methylated in acute myeloid leukemia. Clinical Epigenetics, 11(1), 110. DOI: 10.1186/s13148-019-0709-7.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**